JAMONY
Jacob Asset Management of New York’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $337K | Buy |
327,450
+50,435
| +18% | +$51.9K | 0.48% | 52 |
|
|
2023
Q2 | $321K | Sell |
277,015
-49,642
| -15% | -$57.6K | 0.36% | 54 |
|
|
2023
Q1 | $493K | Buy |
326,657
+59,629
| +22% | +$90K | 0.58% | 47 |
|
|
2022
Q4 | $668K | Buy |
267,028
+27,682
| +12% | +$69.2K | 0.81% | 38 |
|
|
2022
Q3 | $1.01M | Buy |
239,346
+58,336
| +32% | +$246K | 1.1% | 32 |
|
|
2022
Q2 | $505K | Buy |
181,010
+43,755
| +32% | +$122K | 0.51% | 43 |
|
|
2022
Q1 | $785K | Buy |
137,255
+76,897
| +127% | +$440K | 0.48% | 43 |
|
|
2021
Q4 | $551K | Sell |
60,358
-2,740
| -4% | -$25K | 0.25% | 62 |
|
|
2021
Q3 | $675K | Buy |
63,098
+21,098
| +50% | +$226K | 0.25% | 59 |
|
|
2021
Q2 | $652K | Buy |
42,000
+20,000
| +91% | +$310K | 0.22% | 74 |
|
|
2021
Q1 | $357K | Hold |
22,000
| – | – | 0.14% | 74 |
|
|
2020
Q4 | $466K | Buy |
+22,000
| New | +$466K | 0.35% | 51 |
|